Showing results (51-60 of 340) with videos related to
Sort By:
Pageof 34
Diabetes, Obesity & Metabolism|March 16, 2017
The albuminuria-lowering response to dapagliflozin is variable and reproducible among individual patientsSergei I Petrykiv, Gozewijn D Laverman, Dick de Zeeuw, et al.The Journal of Pharmacology and Experimental Therapeutics|June 4, 2004
Low sodium modifies the vascular effects of angiotensin-converting enzyme inhibitor therapy in healthy ratsMenno J A Kocks, Simone Gschwend, Dick de Zeeuw, et al.Journal of Cardiovascular Pharmacology|June 24, 2006
Microalbuminuria and endothelial dysfunction: emerging targets for primary prevention of end-organ damagePeter Ochodnicky, Robert H Henning, Richard P E van Dokkum, et al.Drug Safety|November 15, 2011
Comparing adverse event rates of oral blood glucose-lowering drugs reported by patients and healthcare providers: a post-hoc analysis of observational studies published between 1999 and 2011Liana Hakobyan, Flora M Haaijer-Ruskamp, Dick de Zeeuw, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 30, 2008
A population-based screening for microalbuminuria among relatives of CKD patients: the Kidney Evaluation and Awareness Program in Sheffield (KEAPS)Aminu K Bello, Jean Peters, Jeremy Wight, et al.BMJ Quality & Safety|February 7, 2013
Treatment quality indicators predict short-term outcomes in patients with diabetes: a prospective cohort study using the GIANTT databaseGrigory Sidorenkov, Jaco Voorham, Dick de Zeeuw, et al.Health and Quality of Life Outcomes|August 14, 2014
Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional studySieta T de Vries, Flora M Haaijer-Ruskamp, Dick de Zeeuw, et al.Clinical Journal of the American Society of Nephrology : CJASN|September 20, 2017
Is Chronic Dialysis the Right Hard Renal End Point To Evaluate Renoprotective Drug Effects?Misghina Weldegiorgis, Dick de Zeeuw, Jamie P Dwyer, et al.Journal of Cardiovascular Pharmacology|October 27, 2004
The abnormal renal vasodilator response to D1-like receptor stimulation in conscious SHR can be normalized by AT1 blockadeP A Marcel de Vries, Dick de Zeeuw, Paul E de Jong, et al.Plos One|June 22, 2018
How to measure and monitor albuminuria in healthy toddlers?Sophie Marielle van den Belt, Valentina Gracchi, Dick de Zeeuw, et al.Pageof 34